Chondroïtin

Product description

Chondro'Sea is a specific marine chondroïtin (90% under Eur. Ph monograph). Studies have demonstrated a faster absoprtion than other source of chondroïtins.New Clinical results about Chondro’Sea© efficacy on joint pain, articular comfort and daily mobility. (https://www.pharmanager-ingredients.com/en/ingredients/chondrosea-marine-chondroitin-sulfate-for-healthy-cartilage/)

Randomised, double-blind, placebo-controlled trial

2 Doses: 450mg/d et 900mg/d

Duration: 3 month

180 volunteers

Significant results starting from 450 mg/day

76% of the participants improved their overall WOMAC score.

WOMAC score improvement was 32% 

84% of the participants improved their daily number of steps. 

Improvement of number of steps by 5%

And more results…

Specifications

Categories	Bioactive Compounds - OtherChondroitin sulfate; Specialised Finished ProductsDietary supplements; Bone & Joint Health
Sales markets	Western Europe; Eastern Europe
Supplied from	France
Certifications	Quality assurance

More products from SAS PHARMANAGER GROUP

Nattokinase

Nattiase is specific Nattokinase enzyme developped for the European market under the Novel Food specification. 20 000-28 000 FU/g with a RDI of 100mg maximum. Health benefits: Cardiovascular, cerebral circulation, heavy legs, sports nutrition.

https://www.pharmanager-ingredients.com/en/ingredients...

More info